1
64 D. Bernard Amos Symposium of alloantigen disparities. To test this hypothesis, we have studied the mixed lymphocyte kidney culture (MLKC), a lymphoproliferative response using kidney cortical stimulating cells, and responding infiltrating T lymphocytes isolated from: (i) kidneys of nephrectomized patients with end-stage renal disease (autologous MLKC); or (ii) rejected renal allografts (allogeneic MLKC). In these MLKC reactions, we have previously demonstrated evidence supporting a tissue-specific response reflected in an in vitro cellular immune assay. In further studies, we have now cloned by limiting dilution (>2 month) infiltrating lymphocytes ob- tained from kidneys of groups A and B. In addition, we have cloned peripheral blood T cells obtained from normal volunteers primed in allogeneic MLKC using kidney cortical stimulating cells obtained from unused cadaver kidneys/Group C). The specificity of the clones was demonstrated using cortical cells or lym- phocyte targets of differing HLA-DR antigens. Secondary type MLKC kinetics were observed and several clones responded to renal cortical cells with reactivity unrelated to HLA-DR specificities. In group B, in one experiment, 7/9 clones exhibited activity against donor KC while negative vs. donor spleen lymphocytes and a lymphocyte DR panel. These clones expressed both helper (Leu 3) and suppressor/cytotoxic (Leu 2) antigens. Group A also contained autoreactive kid- ney-specific clones. These studies lend further support to the importance of the role of tissue-specific immunity in the response to an allograft and in a damaged native kidney. SELECTIVE MURINE HUMORAL TOLERANCE TO HUMAN CELLS: TIMING, DOSAGE AND ROUTE OF ADMINISTRATION. Richard J. Sharpe, Robert T. Schweizer, Laine Krisiunas, Patricia A. Michalski, and Laurine M. Bow; Department of Surgical Research, Hartford Hospita/. Hartford, CT 06115 and The University of Conn. School of Medicine Farmington. Connectfiut 06032 There is a large body of literature that shows that tolerance to specific antigen can be induced by exposing neonatal animals to the antigen. Chuma et al. (Cell Immunol 63:193, 1981), working with mice injected with xenogeneic cells neo- natally, were able to induce humoral tolerance to these cells. We have injected neonatal mice with one of a pair of human cell lines within 24 hr of birth either i.p. or i.v. using several dosages. We then immunized the mice with the second cell line at various times and also immunized untreated controls in the same way. Two weeks later the antibody titers of the tolerized and control mice against both cell lines were determined. The results show that sera from a significant number of the mice receiving 10 million or more cells neonatally are strongly reactive towards the immunizing cell yet minimally reactive towards the tolerizing cell. This differential reactivity was most pronounced and consistent in the mice tolerized i.v. and immunized at 21 days. The sera from the control mice react strongly with both cell lines. We hope to use this technique to reduce the number of hybridomas that must be screened to produce monoclonal antibodies to rare cellular determinants. EFFECT OF ACUTE CYCLOSPORINE ADMINISTRATION ON RENAL HEMODYNAMICS IN THE RAT. B. A. Sullivan, L.J. Hak, and W. F. Finn; Schools of Pharmacy and Medicine, University of North Carolina, Chapel Hill, North Carolina 27514 Cyclosporine has become a valuable drug in the field of organ transplantation. However, the occasional occurrence of unique arteriolar lesions in renal biopsy

Selective murine humoral tolerance to human cells: Timing, dosage and route of administration

  • Upload
    vanminh

  • View
    214

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Selective murine humoral tolerance to human cells: Timing, dosage and route of administration

64 D. Bernard Amos Symposium

of alloantigen disparities. To test this hypothesis, we have studied the mixed lymphocyte kidney culture (MLKC), a lymphoproliferative response using kidney cortical stimulating cells, and responding infiltrating T lymphocytes isolated from: (i) kidneys of nephrectomized patients with end-stage renal disease (autologous MLKC); or (ii) rejected renal allografts (allogeneic MLKC). In these MLKC reactions, we have previously demonstrated evidence supporting a tissue-specific response reflected in an in vitro cellular immune assay. In further studies, we have now cloned by limiting dilution (>2 month) infiltrating lymphocytes ob- tained from kidneys of groups A and B. In addition, we have cloned peripheral blood T cells obtained from normal volunteers primed in allogeneic MLKC using kidney cortical stimulating cells obtained from unused cadaver k idneys /Group C). The specificity of the clones was demonstrated using cortical cells or lym- phocyte targets of differing HLA-DR antigens. Secondary type MLKC kinetics were observed and several clones responded to renal cortical cells with reactivity unrelated to HLA-DR specificities. In group B, in one experiment, 7/9 clones exhibited activity against donor KC while negative vs. donor spleen lymphocytes and a lymphocyte DR panel. These clones expressed both helper (Leu 3) and suppressor/cytotoxic (Leu 2) antigens. Group A also contained autoreactive kid- ney-specific clones. These studies lend further support to the importance of the role of tissue-specific immunity in the response to an allograft and in a damaged native kidney.

SELECTIVE MURINE HUMORAL TOLERANCE TO HUMAN CELLS: TIMING, DOSAGE AND ROUTE OF ADMINISTRATION. Richard J. Sharpe, Robert T. Schweizer, Laine Krisiunas, Patricia A. Michalski, and Laurine M. Bow; Department of Surgical Research, Hartford Hospita/. Hartford, CT 06115 and The University of Conn. School of Medicine Farmington. Connectfiut 06032

There is a large body of literature that shows that tolerance to specific antigen can be induced by exposing neonatal animals to the antigen. Chuma et al. (Cell Immunol 63:193, 1981), working with mice injected with xenogeneic cells neo- natally, were able to induce humoral tolerance to these cells. We have injected neonatal mice with one of a pair of human cell lines within 24 hr of birth either i.p. or i.v. using several dosages. We then immunized the mice with the second cell line at various times and also immunized untreated controls in the same way. Two weeks later the antibody titers of the tolerized and control mice against both cell lines were determined. The results show that sera from a significant number of the mice receiving 10 million or more cells neonatally are strongly reactive towards the immunizing cell yet minimally reactive towards the tolerizing cell. This differential reactivity was most pronounced and consistent in the mice tolerized i.v. and immunized at 21 days. The sera from the control mice react strongly with both cell lines. We hope to use this technique to reduce the number of hybridomas that must be screened to produce monoclonal antibodies to rare cellular determinants.

EFFECT OF ACUTE CYCLOSPORINE ADMINISTRATION ON RENAL HEMODYNAMICS IN THE RAT. B. A. Sullivan, L.J. Hak, and W. F. Finn; Schools of Pharmacy and Medicine, University of North Carolina, Chapel Hill, North Carolina 27514

Cyclosporine has become a valuable drug in the field of organ transplantation. However , the occasional occurrence of unique arteriolar lesions in renal biopsy